Summary & Overview
HCPCS L8690: Auditory Osseointegrated Device, All Components
HCPCS Level II code L8690 identifies an auditory osseointegrated device that includes all internal and external components. These implantable bone-conduction hearing systems are important for patients with conductive or mixed hearing loss or single-sided deafness when conventional hearing aids are not suitable. Nationally, this durable medical device category influences surgical supply planning, outpatient follow-up services, and durable medical equipment coverage policies.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines coverage and coding considerations across these major insurers and Medicare, highlighting typical sites of service (operative facility for implantation and outpatient clinics for fitting and maintenance) and the service classification as an implantable durable medical device.
Readers will learn practical benchmarks for billing and coding, an overview of policy and documentation expectations, and clinical context for appropriate use of the device. The summary also points to common modifier usage and payer-specific variations where available. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code L8690 describes an auditory osseointegrated device, inclusive of all internal and external components. This item represents a surgically implanted hearing solution that uses osseointegration to transmit sound via bone conduction.
-
Service type: Durable medical device (implantable auditory prosthesis)
-
Typical site of service: Operative facility for implantation and outpatient setting for device fitting and follow-up
Clinical & Coding Specifications
Clinical Context
A 45-year-old adult with single-sided sensorineural hearing loss and chronic conductive hearing loss after multiple middle ear surgeries presents for evaluation for an osseointegrated auditory implant. The patient has failed conventional hearing aids due to chronic ear drainage and recurrent infections. Preoperative evaluation includes audiologic testing (pure tone audiometry, speech discrimination), CT temporal bone imaging to assess mastoid and cortical bone thickness, medical clearance, and counseling about device components, expected outcomes, and postoperative care. Surgery involves placement of an osseointegrated implant (abutment and internal fixture) with possible intraoperative adjustments; the external sound processor is fitted in a subsequent postoperative visit once osseointegration and wound healing are adequate. Typical sites of service are hospital outpatient surgery departments or ambulatory surgery centers. The clinical workflow includes preoperative ENT and audiology visits, the implant procedure (general or local anesthesia depending on patient factors), a postoperative wound check within 1–2 weeks, device activation and mapping by audiology at approximately 3–6 weeks, and ongoing follow-up for device maintenance and programming.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing only the surgeon or audiologist professional interpretation/component separate from facility charges. |